Medical News

RSS

NASDAQ issues delisting notice to Commonwealth Biotechnologies

On July 24, 2009, The NASDAQ Stock Market notified Commonwealth Biotechnologies, Inc. that CBI was to be delisted from the NASDAQ Capital Market as a result of a failure to comply with NASDAQ Listing Rule 5550(b) due to a failure to maintain minimum stockholders’ equity of $2.5 million and a failure to file a Form 8-K affirming compliance with Rule 5550(b).

24 Oct 2009

Media examines U.S., Mexico H1N1 vaccine campaigns, health effects of handwashing in Bolivia

The Washington Post examines H1N1 vaccine supplies across the U.S.: "With only a fraction of the tens of millions of doses of vaccine that authorities predicted would be available arriving in states, cities and towns, public health officials who spent months planning for a massive immunization program are instead scrambling to parcel out their limited supply of nasal sprays and shots," the newspaper writes.

24 Oct 2009

Wellness and prevention mostly absent in health reform bills

"Despite Americans' poor lifestyle choices and the chronic problems they spawn, the health-care reform proposals being considered in Congress contain relatively little to promote wellness," The Tennessean reports.

24 Oct 2009

Cohen Independent Research Group publishes a report profiling Nutra Pharma

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that Cohen Independent Research Group has published a report profiling Nutra Pharma Corporation.

24 Oct 2009

J.D. Power and Associates certification for Aetna

Aetna (NYSE: AET) has been recognized by J.D. Power and Associates for providing “An Outstanding Customer Service Experience” through its concierge customer service call center. Following a rigorous audit and random survey of Aetna customers, J.D. Power and Associates certified the Aetna call center in High Point, NC, under the J.D. Power and Associates 2009 Call Center Certification ProgramSM.

24 Oct 2009

avVaa World Health Care Products to launch third Direct TV Media Test

avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced their third Direct TV Media Test is scheduled to launch on Thursday October 29.

24 Oct 2009

Dr. Anthony Falcon: We're facing a catastrophic situation on the border

Kaiser Health News staff writer Jessica Marcy talks with Dr. Antonio Falcon, a physician in the border town of Rio Grande City, Texas. He explained his concern "about several health threats facing border communities, including tuberculosis, diabetes, obesity and the H1N1 virus that causes swine flu."

24 Oct 2009

2009 Inspiration Gala raises $1.27 million for BC Cancer Foundation

The 2009 Inspiration Gala raised $1.27 million for the BC Cancer Foundation and colorectal cancer research at the BC Cancer Agency last night, as nearly 400 guests dined and donated during the emotion-filled, sold-out event.

24 Oct 2009

Experienced criminals find new opportunities in medical fraud

Gangsters are getting into the medical fraud business, CNN reports. "Experienced in running drug, prostitution and gambling rings, crime groups of various ethnicities and nationalities are learning it's safer and potentially more profitable to file fraudulent claims with the federal Medicare program and state-run Medicaid plans."

24 Oct 2009

Melinda Gates shares thoughts on U.S. global health efforts

During a recent interview with The Hill's "Blog Briefing Room," Melinda Gates, co-chair of the Bill & Melinda Gates Foundation, praised former President George W. Bush for the enactment of PEPFAR and commended the Obama administration's commitment to global health issues and for "being very open minded [and] saying we don't have to go back and reinvent the wheel."

24 Oct 2009

BD to acquire HandyLab

BD (Becton, Dickinson and Company)announced today that it signed a definitive agreement to acquire HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms. The acquisition is subject to regulatory approvals and is expected to close during the first quarter of fiscal year 2010. The financial terms of the agreement were not disclosed.

From BD (Becton, Dickinson and Company) 24 Oct 2009

Angiotech Pharmaceuticals launches the Tan EndoGlide Endothelium Insertion System in the U.S.

Angiotech Pharmaceuticals, Inc., today announced the commercial launch of the Tan EndoGlide(TM) Endothelium Insertion System in the United States. Angiotech holds exclusive U.S. distribution rights to market and distribute the Tan EndoGlide Endothelium Insertion System, which it obtained in a supply agreement with privately held Network Medical Products, Ltd. Angiotech will launch the product during the American Academy of Ophthalmology meeting, to be held in San Francisco, CA on October 24-27, 2009.

24 Oct 2009

NCD to discuss employment, health care and seclusion issues affecting the disabled

The National Council on Disability (NCD) will hear presentations and discuss employment, health care, and restraint and seclusion issues affecting people with disabilities during its quarterly meeting at the Holiday Inn Express, 920 Broadway, Nashville, TN, which begins at 8:30 a.m. on Monday, October 26, 2009, and concludes at 11:00 a.m. on Wednesday, October 28, 2009.

24 Oct 2009

U.S. District Court rules in favor of Allergan in its patent infringement suit against Exela PharmSci

Allergan, Inc. announced today that the United States District Court for the District of Delaware ruled in favor of Allergan, Inc. in its patent infringement suit against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd. ("Exela"), Apotex, Inc. and Apotex Corp. ("Apotex") (collectively, the "Defendants") for seeking to market purported generic versions of Allergan’s drugs ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%. Specifically, after a trial in March of 2009, the Court ruled today that all five patents (U.S. Patent Nos. 6,627,210; 6,641,834; 6,673,337; 6,562,873; and 5,424,078) asserted by Allergan are valid and enforceable, that Apotex's proposed generic versions of ALPHAGAN® P 0.1% and 0.15% infringe each of the five patents, and that Exela's proposed generic version of ALPHAGAN® P 0.15% infringes U.S. Patent No. 6,641,834, which was the only patent asserted against it. Pursuant to the Hatch-Waxman Act, the United States Food and Drug Administration is required to delay approval of Defendants’ proposed generic products until the last to expire of the infringed patents, which is 2022.

24 Oct 2009

Efforts to measure support for the public option continue

Associated Press: Democratic leaders in Congress scrambled Friday to round up votes for allowing the government to sell health insurance in competition with private industry as they struggled to finalize a health care bill that meets President Barack Obama's goals." Senate Majority Leader Harry Reid spent Friday "calling and talking with wavering Democrats to test support for different versions of the plan."

24 Oct 2009

Clinical results of FlexStent Femoropopliteal Self Expanding Stent System presented

Interim six month clinical results on the use of the FlexStent Femoropopliteal Self Expanding Stent System in the Superficial Femoral Artery were presented today at the VIVA conference by Dr. William Gray of NY Columbia-Presbyterian Hospital.

24 Oct 2009

Congress reauthorizes Ryan White Care Act - funding for HIV/AIDS

The New York Times: "The House on Wednesday overwhelmingly passed legislation allocating billions of dollars in federal money for the treatment of HIV and AIDS. By a vote of 408-9, the House reauthorized the Ryan White Care Act, first enacted in 1990 and named for the Indiana teenager who died of AIDS. The Senate has already passed the bill by unanimous consent."

24 Oct 2009

Bio-Rad Laboratories to acquire diagnostic businesses of Biotest AG for 45 million euros

Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has signed an agreement to acquire certain diagnostic businesses of Biotest AG for 45 million euros.

24 Oct 2009

HHS funds $17M for fight against costly and dangerous health care-associated infections

HHS Secretary Kathleen Sebelius today announced the award of $17 million to fund projects to fight costly and dangerous health care-associated infections, or HAIs.

24 Oct 2009

AcuMedSpa Holdings to launch online marketing campaign

AcuMedSpa Holdings, Inc., which owns and operates multiple Medical Spa locations throughout South Florida has reached an agreement to launch a major Online Marketing Campaign as well as improve AMSZ's web presence through SEO and website redesign and user friendliness with ARC Media Consultants.

24 Oct 2009